Natera is a diagnostics company that offers blood tests for cancer, women's health and organ health. It last closed at $273.40 on Nov 20, down 5.70% on the day. The next earnings report for NTRA is expected around Mon, Jan 11, 2027, after the close. For the quarter ended Sep 2026, NTRA reported EPS of -$0.42 on revenue of $794.0M, with revenue up 34.1% from a year ago. Over its last 8 reports the stock moved an average of 8.4% the session after earnings. Over the last 12 months NTRA insiders bought $0 of stock on the open market and sold $365.6M, according to SEC Form 4 filings.
AI Auto Pilots
Is NTRA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold NTRA.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on NTRAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
NTRA · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, oversold
The stock is 27% below its 20 day and 37% below its 50 day average. It is sitting right on its 200 day average, a level many traders watch. Momentum is weak (RSI 26), oversold. The nearest support is the 200 day average at $273.05, and the nearest resistance the Pivot at $277.88.
Short trendBearish
Long trendBullish
MomentumWeak
StretchOversold
VolatilityHigh, 7.7%/day
Key levels
$437.4152 week high+60.0%
$375.5250 day average+37.4%
$347.3220 day average+27.0%
$336.17100 day average+23.0%
$283.92Pivot R1+3.8%
$282.00Swing high (Jul 16)+3.1%
$277.88Pivot+1.6%
$273.40Last close
$273.05200 day average−0.1%
$267.37Pivot S1−2.2%
$261.63Swing low (Jul 13)−4.3%
$181.0052 week low−33.8%
Indicators
RSI (14)
26.15
Oversold below 30
Oversold
MACD
-28.90
Below its signal line
Bearish
Stochastic
6.1
Near the bottom of its range
Oversold
ADX (14)
43.3
Strong downtrend
Williams %R
-98.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-96.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−12.0%
Change over 10 sessions
Bearish
ATR (14)
$20.96
Typical daily range, 7.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Moving sideways
Short trendNeutral
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 13.1%/day
Key levels
$437.4152 week high+60.0%
$375.5250 day average+37.4%
$347.3220 day average+27.0%
$336.17100 day average+23.0%
$283.92Pivot R1+3.8%
$282.00Swing high (Jul 16)+3.1%
$277.88Pivot+1.6%
$273.40Last close
$273.05200 day average−0.1%
$267.37Pivot S1−2.2%
$261.63Swing low (Jul 13)−4.3%
$181.0052 week low−33.8%
Indicators
RSI (14)
42.38
Middle of its range
Neutral
MACD
24.55
Below its signal line
Bearish
Stochastic
13.6
Near the bottom of its range
Oversold
ADX (14)
39.3
Trending down
Williams %R
-99.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-75.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−16.9%
Change over 10 sessions
Bearish
ATR (14)
$35.87
Typical daily range, 13.1% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for NTRA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how NTRA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow NTRA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for NTRAHow many large options trades hit NTRA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in NTRA in the last 90 days.
From SEC Form 4 filings by NTRA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NTRA is in one of them and how their past NTRA trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Natera
Natera is a diagnostics company based in Austin, Texas, that uses blood tests built on genetic analysis to guide medical decisions. Its tests cover cancer, including Signatera, which tracks disease that may remain or return after treatment, women's health, including prenatal and hereditary cancer screening, and organ health, including transplant rejection and kidney disease. The company sells its tests directly in the United States and through laboratory partners worldwide, serving physicians, patients and cancer researchers.